Scientific leader in translational immuno-oncology, drug discovery, pre-clinical biomarker, computational biology and cancer diagnostics with over 15 years of combined industry and academic experience at MIT, Harvard Medical School and Dana-Farber Cancer Institute. A solid record of over 170 publications in peer-reviewed scientific journals with more than 13000 citations to date.